Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2979204 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| recent advances in our knowledge of the human major histcompatibility complex antigens-hla antigens, which have an important role in transplantation immunity, are herein reviewed briefly and the relation to allograft rejection is discussed. | |||||||
| 2979958 | HLA (HLA) | dipyridamole | NA | heparin | NA | unclassified | |
| NA | |||||||
| 2979958 | HLA (HLA) | dipyridamole | NA | heparin | NA | unclassified | |
| NA | |||||||
| 2986745 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| this investigation uses different polyclonal activators of in vitro immunoglobulin production to elicit immunoregulatory profiles of b cells, t cells, t4 cells, and t8 cells from 25 recipients (13 with and 12 without chronic graft-v-host disease [gvhd] ) after hla-identical marrow transplantation for aplastic anemia or hematologic malignancy. | |||||||
| 2986745 | HLA IDENTICAL (HLA-IDENTICAL) | aplastic anemia | NA | NA | NA | unclassified | |
| this investigation uses different polyclonal activators of in vitro immunoglobulin production to elicit immunoregulatory profiles of b cells, t cells, t4 cells, and t8 cells from 25 recipients (13 with and 12 without chronic graft-v-host disease [gvhd] ) after hla-identical marrow transplantation for aplastic anemia or hematologic malignancy. | |||||||
| 2986745 | HLA IDENTICAL (HLA-IDENTICAL) | hematologic malignancy | NA | NA | NA | unclassified | |
| this investigation uses different polyclonal activators of in vitro immunoglobulin production to elicit immunoregulatory profiles of b cells, t cells, t4 cells, and t8 cells from 25 recipients (13 with and 12 without chronic graft-v-host disease [gvhd] ) after hla-identical marrow transplantation for aplastic anemia or hematologic malignancy. | |||||||
| 2986745 | HLA IDENTICAL (HLA-IDENTICAL) | bone marrow transplantation | NA | NA | NA | unclassified | |
| the regulation of immunoglobulin synthesis after hla-identical bone marrow transplantation: vi. | |||||||
| 2990383 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| the patients were matched for age, number of transplants, time of transplantation, diabetic status, living-related vs cadaveric donor, and number of hla matches. | |||||||
| 2990383 | HLA (HLA) | cadaver | NA | NA | NA | unclassified | |
| the patients were matched for age, number of transplants, time of transplantation, diabetic status, living-related vs cadaveric donor, and number of hla matches. | |||||||
| 2992676 | HLA-DR6 (BROAD ANTIGEN) | transplantation | NA | NA | NA | negation | |
| hla-drw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation. | |||||||
Copyright 2024